Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2, Randomized, Investigator and Participant bLInded, placeBo-controllEd, paRallel-group Study to Investigate the sAfety, Tolerability, and Preliminary Efficacy of TMP-301 TrEatment in Adult Patients With Alcohol Use Disorder (AUD)

NCT06648655 is registered in ClinicalTrials.gov with Tempero Bio, Inc. as lead sponsor.

NCT NCT06648655
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06648655 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2, Randomized, Investigator and Participant bLInded, placeBo-controllEd, paRallel-group Study to Investigate the sAfety, Tolerability, and Preliminary Efficacy of TMP-301 TrEatment in Adult Patients With Alcohol Use Disorder (AUD)
Lead sponsor
Tempero Bio, Inc.
Phase
Phase 2
Overall status
Terminated
Start date
November 14, 2024
Completion date
November 14, 2025
Enrollment
110 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol use disorder (aud)